Cargando…

Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression

The prognostic potential of anti-tumor immune responses is becoming increasingly important in adenocarcinoma of the gastroesophageal junction and stomach (AGE/S) especially regarding the use of immune checkpoint inhibitors. This study analyzes for the first time the prognostic impact of tumor-infilt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pötzsch, M., Berg, E., Hummel, M., Stein, U., von Winterfeld, M., Jöhrens, K., Rau, B., Daum, S., Treese, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553533/ https://www.ncbi.nlm.nih.gov/pubmed/33101772 http://dx.doi.org/10.1080/2162402X.2020.1824632

Ejemplares similares

Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
por: Arnold, A., et al.
Publicado: (2020)

Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas
por: Staudacher, J. J., et al.
Publicado: (2022)

S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus
por: Treese, Christoph, et al.
Publicado: (2022)

Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas
por: Treese, Christoph, et al.
Publicado: (2022)

Hereditary Diffuse Gastric Cancer—Update Based on the Current Consort Recommendations
por: Treese, Christoph, et al.
Publicado: (2022)

Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies
por: Kleo, Karsten, et al.
Publicado: (2022)

The ratio of intratumour to stromal infiltrating lymphocytes better predicts prognosis in breast cancer
por: Zhang, Baoyi, et al.
Publicado: (2023)

Association of tumor deposits with tumor-infiltrating lymphocytes and prognosis in gastric cancer
por: Li, Xinyue, et al.
Publicado: (2022)

Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins
por: Gordon-Alonso, Monica, et al.
Publicado: (2014)

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
por: Darb-Esfahani, Silvia, et al.
Publicado: (2015)

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
por: Däster, Silvio, et al.
Publicado: (2020)

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
por: Qin, Miao, et al.
Publicado: (2023)

Tumor-Infiltrating Lymphocyte-Based Risk Score for Predicting Prognosis in Gastric Cancer
por: Xie, Siyuan, et al.
Publicado: (2020)

Profiling the Tumor-Infiltrating Lymphocytes in Gastric Cancer Reveals Its Implication in the Prognosis
por: Yu, Weiqiang, et al.
Publicado: (2022)

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
por: Ding, Naiqing, et al.
Publicado: (2019)

Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas
por: Kim, Jung Ryul, et al.
Publicado: (2013)

Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer
por: Sun, Chenglong, et al.
Publicado: (2020)

Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas
por: Treese, Christoph, et al.
Publicado: (2016)

PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma
por: Cao, Jinfeng, et al.
Publicado: (2017)

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
por: Bevins, Nicholas J., et al.
Publicado: (2022)

Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer
por: Fang, Wenfeng, et al.
Publicado: (2017)

Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer
por: Bae, Sang Byung, et al.
Publicado: (2016)

Tumor-infiltrating CCR2(+) inflammatory monocytes counteract specific immunotherapy
por: Bartneck, Joschka, et al.
Publicado: (2023)

iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung Cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2020)

BDNF expression in GISTs predicts poor prognosis when associated with PD-L1 positive tumor-infiltrating lymphocytes
por: Tian, Guang-Ang, et al.
Publicado: (2021)

High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour‐associated T lymphocyte infiltration
por: Li, Huafu, et al.
Publicado: (2020)

Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b
por: Volz, Magdalena Sarah, et al.
Publicado: (2015)

Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort †
por: Schölzchen, Jan, et al.
Publicado: (2022)

Tumour-infiltrating lymphocytes: from prognosis to treatment selection
por: Brummel, Koen, et al.
Publicado: (2022)

An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
por: Acs, Balazs, et al.
Publicado: (2019)

Immune Cell Infiltrate and Prognosis in Gastric Cancer
por: Kemi, Niko, et al.
Publicado: (2020)

Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas
por: Choi, Euno, et al.
Publicado: (2020)

PD-L1 Expression and CD8(+) T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer
por: Wang, Yangyang, et al.
Publicado: (2018)

High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2023)

Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Expression of immune checkpoints (PD-L1 and IDO) and tumour-infiltrating lymphocytes in breast cancer
por: Alkhayyal, Noura, et al.
Publicado: (2022)

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
por: Lee, H E, et al.
Publicado: (2008)

Prognosis of tumor infiltrating lymphocytes in operable tongue cancer patients
por: Chen, Wan-Yu, et al.
Publicado: (2014)

PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC
por: Ameratunga, Malaka, et al.
Publicado: (2016)

PD-L1 Expression and Tumor-Infiltrating Lymphocytes in Thymic Epithelial Neoplasms
por: Higuchi, Rumi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4fc3c5r80olis3ki6iaompjd8k